Vietnam Pelvic Inflammatory Disease Market (2025-2031) | Outlook, Analysis, Growth, Share, Segmentation, Forecast, Competitive Landscape, Companies, Size & Revenue, Value, Trends, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Vietnam Country Macro Economic Indicators

3.2 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, 2021 & 2031F

3.3 Vietnam Pelvic Inflammatory Disease Market - Industry Life Cycle

3.4 Vietnam Pelvic Inflammatory Disease Market - Porter's Five Forces

3.5 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume Share, By End User, 2021 & 2031F

3.7 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about pelvic inflammatory disease (PID) and its consequences among women in Vietnam

4.2.2 Rising prevalence of sexually transmitted infections (STIs) leading to a higher incidence of PID

4.2.3 Improving healthcare infrastructure and access to gynecological services in Vietnam

4.3 Market Restraints

4.3.1 Limited understanding and underdiagnosis of PID in Vietnam

4.3.2 Stigma and cultural barriers preventing women from seeking timely medical help for PID

4.3.3 Lack of standardized protocols and guidelines for the diagnosis and treatment of PID in Vietnam

6.1 Vietnam Pelvic Inflammatory Disease Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Macrolides, 2021- 2031F

6.1.4 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Tetracycline, 2021- 2031F

6.1.5 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Beta-lactam, 2021- 2031F

6.1.6 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Nitroimidazoles, 2021- 2031F

6.1.7 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Others, 2021- 2031F

6.2 Vietnam Pelvic Inflammatory Disease Market, By End User

6.2.1 Overview and Analysis

6.2.2 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Homecare, 2021- 2031F

6.2.4 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.2.5 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Others, 2021- 2031F

6.3 Vietnam Pelvic Inflammatory Disease Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.3.3 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.3.4 Vietnam Pelvic Inflammatory Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7.1 Vietnam Pelvic Inflammatory Disease Market Export to Major Countries

7.2 Vietnam Pelvic Inflammatory Disease Market Imports from Major Countries

8.1 Average time from symptom onset to diagnosis of PID

8.2 Percentage of women receiving PID screening during routine gynecological visits

8.3 Rate of PID complications requiring hospitalization

9.1 Vietnam Pelvic Inflammatory Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Vietnam Pelvic Inflammatory Disease Market Opportunity Assessment, By End User, 2021 & 2031F

9.3 Vietnam Pelvic Inflammatory Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Vietnam Pelvic Inflammatory Disease Market Revenue Share, By Companies, 2024

10.2 Vietnam Pelvic Inflammatory Disease Market Competitive Benchmarking, By Operating and Technical Parameters